doctor Find a doctor
OR
Breadcrumbs that show current page

Participate in Research or Clinical Trials

If you have any questions or do not see the study you are interested in, please contact the Clinical Trial Office at [email protected].

Project Title

ClinicalTrials.Gov Link Principal Investigator Department Section
ADOLESCENT MASTER PROTOCOL FOR PARTICIPANTS 18 YEARS OF AGE AND OLDER – LITE (AMP UP LITE) (PHACS Protocol PH400) Ellen Cooper Pediatrics Pediatric Infectious Diseases
A single-center, randomized, double-blind, double-dummy, parallel-group study comparing oral sedation to intravenous sedation Manju Subramanian Ophthalmology N/A
A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external support for arteriovenous fist Alik Farber Surgery Vascular and Endovascular Surgery
A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years Elizabeth Barnett Pediatrics Pediatric Infectious Diseases
Safety and Immunogenicity of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults (Centers for Disease Elizabeth Barnett Pediatrics Pediatric Infectious Diseases
A multi-center, single-blind, randomized clinical trial to compare two copper IUDs:Mona Lisa NT Cu380 Mini and ParaGard Katharine White Obstetrics/Gynecology General Gynecology
An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediat Vishaka Sabharwal Pediatrics Pediatric Infectious Diseases
Randomized Trial Comparing the Boston Scientific RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty for the Alik Farber Surgery Vascular and Endovascular Surgery
Immunogenicity of Influenza, Pneumococcal, and Hepatitis B vaccines in Inflammatory Bowel Disease patients treated with Vedol Sharmeel Wasan Medicine Gastroenterology
Evomela - A Phase II Single-Center, Open-Label, Safety and Efficacy Study of Propylene Glycol-Free Melphalan Hydrochloride (E Shayna Sarosiek Cancer Care Center N/A
Evaluation of the impact of Point of Care Liat Influenza A/B Testing in the Emergency Department at Boston Medical Center Elissa Perkins Emergency Medicine N/A
S1418 - A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Lauren Oshry Medicine Hematology and Medical Oncology
S1605 - Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer Gretchen Gignac Medicine Hematology and Medical Oncology
A Phase I-II Trial of Daratumumab for the treatment of patients with AL amyloidosis Vaishali Sanchorawala Cancer Care Center N/A
Impact of Smoking and its Cessation on Systemic and Airway Immune Activation Nina Lin Medicine Infectious Diseases
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia (ITX5) Stephen Christiansen Ophthalmology N/A
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (treetoP) Glenn Markenson Obstetrics/Gynecology Maternal-Fetal Medicine
Evaluation of medium chain triglycerides in a mixed racial population of patients with metabolic syndrome: a feasibility stud Caroline Apovian Medicine Endocrinology, Diabetes and Nutrition
Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection (IMPAACT Ellen Cooper Pediatrics Pediatric Infectious Diseases
Study Title:SWOG #S1500: A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #7 Gretchen Gignac Cancer Care Center N/A
A011401 - RANDOMIZED PHASE III TRIAL EVALUATING THE ROLE OF WEIGHT LOSS IN ADJUVANTTREATMENT OF OVERWEIGHT AND OBESE WOMEN W Lauren Oshry Medicine Hematology and Medical Oncology
Women in Control: A Virtual World Study of Diabetes Self-Management (Women in Control 2.0) Suzanne Mitchell Family Medicine N/A
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to EvaluateEfficacy and Safety of BMS-986141 Fo Rafael Jose Romero Neurology Stroke
AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICDimplantation in NYHA class II & III he Robert Helm Medicine Cardiology
A double blind, randomized, placebo-controlled trial evaluating efficacy and safety of oral nintedanib, 150 mg twice daily fo Robert Simms Arthritis Center N/A
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter study to investigate the Efficacy and Safety of Mongerse Francis Farraye Medicine Medicine
EA5142: Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resect Marjory Charlot Medicine Hematology and Medical Oncology
Janssen: Efficacy and Safety of Rivaroxaban Prophylaxis Compared withPlacebo in AmbulatoryCancer Patients Initiating Systemi John Sloan Medicine Hematology and Medical Oncology
DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE TREATMENT OF CHRONIC LARYNGITIS WITH AMITRIPTYLINE Pieter Noordzij Otolaryngology - Head and Neck Surgery N/A
Detection of Early Lung Cancer Among Military Personnel (DECAMP-2):  Screening of Patients with Early Stage Lung Cancer of at Avrum Spira Medicine Computational Biomedicine
Alcohol Disorder hosPital Treatment (ADOPT) Study Richard Saitz Medicine General Internal Medicine
CTSU #EAY131:  Molecular Analysis for Therapy Choice (MATCH) Marjory Charlot Cancer Care Center N/A
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Thera Francis Farraye Medicine Gastroenterology
Prevention of Recurrence of Crohn’s Disease by Fecal Microbiota Therapy (FMT) Francis Farraye Medicine Gastroenterology
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE). Jeffrey Kalish Surgery Vascular and Endovascular Surgery
Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE (A5332) Nina Lin Medicine Infectious Diseases
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered by Single or Multi-Dose Intravitreal Inje Crandall Peeler Ophthalmology N/A
Open-Label, Dose-Escalating, Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous (SC) VRC01, a P Ellen Cooper Pediatrics Pediatric Infectious Diseases
SWOG #S1320: A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib ( Adam Lerner Medicine Hematology and Medical Oncology
NRG #BN001: Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy versus Convention Minh-Tam Truong Cancer Care Center N/A
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects w Alice Jacobs Medicine Cardiology
ANCHOR Study: Anal Cancer/ High-grade squamous intraepithelial lesions (HSIL) Outcomes Research Study Elizabeth Stier Obstetrics/Gynecology General Gynecology
NRG #HN001: Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Bioma Minh-Tam Truong Medicine Hematology and Medical Oncology
Mild and Rapidly Improving Stroke Study (MaRISS) Rafael Jose Romero Neurology Stroke
Randomized, Multicenter, Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients with Critical Jeffrey Kalish Surgery Vascular and Endovascular Surgery
A Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of C Ellen Cooper Pediatrics Pediatric Infectious Diseases
A Multicenter, International, Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Efficacy, Safety, a John Berk Medicine Amyloid Research & Training Program
An Observational Study of Hepatitis C Virus in Pregnancy (MFMU/NICHD protocol) Stephen Pelton Pediatrics Pediatric Infectious Diseases
Improving Outcomes in Neonatal Abstinence Syndrome (NAS) Michael Silverstein Pediatrics Pediatric General
CTSU #E1412:  Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Dox John Sloan Medicine Hematology and Medical Oncology
Raltegravir Pharmacokinetics and Safety in Neonates (IMPAACT P1097, Version 2.0, dated 22 January 2014) Ellen Cooper Pediatrics Pediatric Infectious Diseases
Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery
A PHASE I TRIAL TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF RALTEGRAVIR IN HIV-1-EXPOSED NEONATES AT HIGH RISK OF ACQUIRIN Ellen Cooper Pediatrics Pediatric Infectious Diseases
AMC #085: A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the treatment of stage II-IV HIV-associated Hodgkin Lympho Mark Sloan Medicine Hematology and Medical Oncology
SWOG #S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Lauren Oshry Cancer Care Center N/A
Millennium C16011: A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plu Vaishali Sanchorawala Medicine Hematology and Medical Oncology
FEASIBILITY/OUTCOMES STUDY OF HYPOFRACTIONATED STEREOTACTIC BODY RADIATION THERAPY AS A BOOST TO THE PROSTATE FOR TREATMENT O Ariel Hirsch Radiation Oncology N/A
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA Trial Protocol) Claudia Hochberg Medicine Cardiology
A Phase II Multi-Center Study of High-Dose Cyclophosphamide and Antithymocyte GlobulinFollowed by Autologous Hematopoietic C Robert Simms Medicine Rheumatology
RTOG #R0920: A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND Minh-Tam Truong Radiation Oncology N/A
INTRAMEDULLARY NAILS VERSUS PLATE FIXATION RE-EVALUATION STUDY IN PROXIMAL TIBIA FRACTURES: A MULTICENTER RANDOMIZED TRIAL CO Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL AND RELATED DRUGS DURING PREGNANCY AND POSTPARTUM (IMPAACT P1026S) Mark Mirochnick Pediatrics Pediatric Infectious Diseases